New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients

Current Opinion in Infectious Diseases

Volumn 23, Issue 6, 2010, Pages 567-577

  Chen, Sharon C A ^a   Kontoyiannis, Dimitrios P ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

bacteria; fungi; infection biomarkers; nucleic acid amplification

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; DNA 18S; ECHINOCANDIN; FLUCONAZOLE; GALACTOMANNAN; INTERLEUKIN 6; INTERLEUKIN 8; INTERNAL TRANSCRIBED SPACER; PEPTIDE NUCLEIC ACID; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ASPERGILLUS; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; CANDIDEMIA; DIAGNOSTIC ACCURACY; DISEASE MARKER; DNA EXTRACTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEBRILE NEUTROPENIA; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; GENE TARGETING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HISTOPLASMOSIS; HUMAN; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE MYELOMA; MYCOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SCREENING; TREATMENT RESPONSE;

ANTIGENS, FUNGAL; BACTEREMIA; BIOLOGICAL MARKERS; DNA, BACTERIAL; DNA, FUNGAL; FEVER; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; NEUTROPENIA; PATHOLOGY, MOLECULAR; POLYMERASE CHAIN REACTION;

EID: 78349304556     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833ef7d1     Document Type: Review

References (95)

1. Hamalainen S, Kuittinen T, Matiniauri I, et al. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma 2008; 49:495-501.
2. Einsele H, Loeffler J. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk hematology patients. Clin Microbiol Infect 2008; 14 (Suppl 4):37-45.
3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20:133-163.
4. Slavin M, Sorrell T, Marriott D, et al. Candidemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 2010; 65:1042-1051.
5. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretative breakpoints. J Clin Microbiol 2008; 46:2620-2629.
6. Upton A, Kirby KA, Carpenter P, et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44:531-540.
7. Kontoyiannis DP, Marr KA, ParkBJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091-1100.
8. Delinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36:296-327.
9. Hsu DL, Nguyen M, Nguyen L, et al. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in nonimmunocompromized adult patients. J Antimicrob Chemother 2010; 65:1765-1770.
10. Mancini N, Clerici D, Diotti R, et al. Molecular diagnosis of sepsis in neutropenic patients with hematological malignancies. J Med Microbiol 2008; 57:601-604.
11. Mancini M, Carletti S, Ghidoli N, et al. The era of molecular and other nonculture-based methods in diagnosis of sepsis. Clin Microbiol Rev 2010; 23:235-251.
12. Lau A, Chen S, Sleiman S, Sorrell T. Current status and future perspectives on molecular and serological methods in diagnostic mycology. Future Microbiol 2009; 4:1185-1222.
13. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006; 19:165-256.
14. Parida M, Sannarangaiah S, Dash PK, et al. Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev Med Virol 2008; 18:407-421.
15. Miller MB, Tang Y-W. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009; 22:611-633.
16. Woo PCY, Lau SKP, Teng JLL, et al. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect 2008; 14:908-934.
17. Lehmann LE, Hunfeld KP, Emrich T, et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immun 2008; 197:313-324.
18. Stormer M, Kleesiak K, Dreir J. High-volume extraction of nucleic acids by magnetic bead technology for ultrasensitive detection of bacteria in blood components. Clin Chem 2007; 53:104-110.
19. Zhao Y, ParkS, Kreiswirth BN, et al. A rapid real-time nucleic acid sequence-based amplification (NASBA): molecular beacons platform to detect fungal and bacterial bloodstream infections. J Clin Microbiol 2009; 47:2067-2078.
20. White PE, Bretagne S, Klingspor K, et al. Aspergillus PCR: one step closer towards standardization. J Clin Microbiol 2010; 48:1231-1240.
21. Gebert S, Siegel D, Wellinghausen N. Rapid detection of pathogens in blood culture bottles by real time PCR in conjunction with the preanalytic tool MolYsis. J Infect 2008; 57:307-316.
22. Ruimy R, Dos-Santos M, Raskine L, et al. Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered Gram-positive cocci on direct smears. J Clin Microbiol 2008; 46:2045-2051.
23. Lau A, Sorrell TC, Chen S, et al. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens form blood culture specimens. J Clin Microbiol 2008; 46:3021-3027.
24. Lau A, Halliday C, Chen SC-A, et al. Comparison of whole blood, serum and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 2010; 48:811-816.
25. Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid accurate and cost-effective diagnostic method for infectious diseases. J Infect Chemother 2009; 15:62-69.
26. Inacio J, Flores O, Spencer-Martins I. Efficient identification of clinically relevant Candida yeast species by use of an assay combining panfungal loop-mediated isothermal DNA amplification with hybridization to species-specific oligonucleotide probes. J Clin Microbiol 2008; 46:713-720.
27. Uemura N, Makimura K, Onozaki M, et al. Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia. J Med Microbiol 2008; 57:50-57.
28. Forrest GN, Roghmann MC, Toombs LS, et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008; 52:3558-3563.
29. Hermsen ED, Shull SS, Klepser DG, et al. Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles. J Clin Microbiol 2008; 46:2924-2929.
30. Ly T, Gulia J, Pyrgos V, et al. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manage 2008; 4:637-640.
31. Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46:50-55.
32. Forrest GN. Early diagnosis of blood culture isolates in patients with candidemia using PNA FISH. Curr Fungal Infect Rep 2008; 2:221-226.
33. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PloS ONE 2009; 4:e8041.
34. Marklein G, Josten M, Klanke U, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009; 47:2912-2917.
35. Hummel M, Spiess B, Roder J, et al. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J Med Microbiol 2009; 58:1291-1297.
36. Tuon FF. A systematic review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 2007; 24:89-94.
37. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveaolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009; 49:1688-1693.
38. HardakE, Yigla M, Avivi A, et al. Impact of PCR-based diagnosis of invasive aspergillosis on clinical outcome. Bone Marrow Transpl 2009; 44:595-599.
39. Klingspor L, Loeffler J. Aspergillus PCR formidable challenges and progress. Med Mycol 2009; 47 (Suppl 1):S241-S247.
40. Mengoli C, Cruciani M, Barnes RA, et al. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9:89-96.
41. Hebart H, Loeffler J, Meisner C, et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000; 181:1713-1719.
42. Buchheidt D, Hummel M, Scheiermacher D, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and hematological stem cell transplant recipients. Br J Hematol 2004; 125:196-202.
43. Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42:2733-2741.
44. Jordanides NE, Allan EK, McLintock LA, et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in hemato-oncology patients. Bone Marrow Transplant 2005; 35:389-395.
45. Halliday C, Hoile R, Sorrell TC, et al. Role of prospective screening by a panfungal polymerase chain reaction in febrile neutropenic recipients of hematopoietic stem cell transplants and patients with acute leukemia. Br J Hematol 2006; 132:478-486.
46. Scotter JM, Campbell P, Anderson TP, et al. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005; 37:246-253.
47. White PL, Linton CJ, Perry MD, et al. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006; 42:479-486.
48. Badiee P, Kordbacheh P, Alborzi A, et al. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 2008; 36:580-584.
49. Suarez F, Lortholary O, Buland S, et al. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol 2008; 46:3772-3777.
50. Kami M, Fukui T, Ogawa S, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33:1504-1512.
51. Cuenca-Estrella M, Meije Y, Diaz-Pedroche C, et al. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J Clin Microbiol 2009; 47:379-384.
52. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organisation for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-1821.
53. Florent M, Katsahian S, Vekhoff A, et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006; 193:741-747.
54. Hummel M, Spiess B, Cornerly O, et al. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial. Eur J Hematol 2010; 85:164-169.
55. Westh H, Lisby G, Breysse F, et al. Multiplex real-time PCR and blood culture for identification of blood stream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009; 15:544-551.
56. Varani S, Stanzani M, Paolucci M, et al. Diagnosis of blood stream infections in immunocompromized patients by real-time PCR. J Infect 2009; 58:346-351.
57. von Lilienfeld-Toal M, Lehmann LE, Raadts AD, et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 2009; 47:2405-2410.
58. Ecker DJ, Sampath R, Li H, et al. New technology for rapid molecular diagnosis of bloodstream infections. Exper Rev Mol Diagn 2010; 10:399-415.
59. Dierkes C, Ehrenstein B, Siebig S, et al. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens with pre sumed sepsis. BMC Infect Dis 2009; 9:126.
60. Wellinghausen N, Kochem A-J, Disqué C, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 1 6S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009; 47:2759-2765.
61. Tissari P, ZumlaA,TarkkaE, et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010; 375:224-230
62. Gupta R, Mirdha BR, Guleria R, et al. Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jiroveci in respiratory clinical specimens. Diagn Microbiol Infect Dis 2009; 64:381-388.
63. Fujisawa T, Suda T, Matsuda H, et al. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromized patients without HIV. Respirology 2009; 14:203-209.
64. Azoulay E, Bergeron A, Chevret S, et al. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromized patients with pulmonary infiltrates. Chest 2009; 135:655-661.
65. Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 2008; 27:245-251.
66. Maertens JA, Klont R, Masson C, et al. Optimization of the cutoff for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007; 44:1329-1336.
67. Pazos C, Ponton D, Del Palacio A. Contribution of 1,3 beta-D-glucan chromogenic assay for the diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galaatomannan. J Clin Microbiol 2005; 43:299-305.
68. Penack O, Rempf P, Graf B, et al. Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management. Ann Oncol 2008; 19:984-989.
69. Guo YL, Chen YQ, Wang K, et al. Accuracy of bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis: a bivariate meta-analysis and systematic review. Chest 2010 [Epub ahead of print].
70. Woods G, Miceli MH, Grazziutti ML, et al. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis. Cancer 2007; 110:830-834.
71. Miceli MH, Grazziutti ML, Woods G, et al. Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis 2008; 46:412-422.
72. Maertens J, Buve K, Theunissen K, et al. Galactomannnan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 2008; 115:355-362.
73. Klont RR, Mennink-Kersten MA, Ruegebrink D, et al. Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. Clin Infect Dis 2006; 43:e23-e25.
74. Mennink-Kersten MASH, Ruegebrink D, Klont RR, et al. Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure. J Clin Microbiol 2008; 46:1391-1397.
75. Mori Y, Nagasaki Y, Kamezaki K, et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am J Hematol 2010; 85:449-451.
76. Odabasi T, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199-205.
77. Ellis M, Al-Ramadi B, Finkelman M, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008; 57:287-295.
78. Senn L, Robinson JO, Schmidt S, et al. 1,3-beta-d-Glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46:878-885.
79. Hachem RY, Kontoyiannis DP, Chemaly RF, et al. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009; 47:129-133.
80. Persat F, Ranque S, Deroiun F, et al. Contribution of the (1,3)-B-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008; 46:1009-1013.
81. Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1-3)-beta-D-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46:1864-1870.
82. Koo S, Bryant JM, Page JH, et al. Diagnostic performance of the (1-3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49:1650-1659.
83. Marty FM, Koo S. Role of (1-3)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med Mycol 2009; 47 (Suppl 1):S233-240.
84. Wiederhold NP, Najvar LK, Vallor AC, et al. Assessment of serum (1,3)-B-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. J Clin Microbiol 2008; 52:1176-1178.
85. Pisculli ML, Sax PE. Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jirovecii pneumonia in patients with negative microscopic examination results. Clin Infect Dis 2008; 46:1928-1930.
86. DesmetS, Van Wijngaerden E, Maertens J, et al. Serum (1,3)-β-D- glucan as a tool for diagnosis of Pneumocystisjirovecii pneumonia in patients with human immunodeficiency virus infection or haematological malignancy. J Clin Micro-biol 2009; 47:3871-4874.
87. Ellis M, Al-Ramadi B, Bernsen R, et al. Prospective evaluation of mannan and antimannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009; 58:606-615.
88. Verduyn Lunel FM, Donnelly JP, van der Lee HAL, et al. Circulating Candida-specific antimannan antibodies precede invasive candidiasis in patients treated with myeloablative chemotherapy. Clin Microbiol Infect 2009; 15:380-386.
89. Limper M, de Kruif MD, Duits AJ, et al. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from noninfectious fever. J Infect 2010; 60:409-416.
90. Hatzistilianou M, Rekliti A, Athanassiadou F, Catriu D. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lym-phoblastic leukemia. Inflam Res 2010; 59:339-347.
91. Sakr Y, Sponholz C, Tuche F, et al. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008; 36:396-407;
92. markers in febrile neutropenic adults. BMC Infect Dis 2007; 7:137.
93. Martinez-Albarran M, Perez-Molina Jde J, Gallegos-Castorena S, et al. Procalcitonin and C-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer. Pediatr Oncol 2009; 26:414-425.
94. Buyukberber N, Buyukberber S, Sevinc A, Camci C. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients. Med Oncol 2009; 26:55-61.
95. Armenian S, Nash K, Kapoor N, et al. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients. J Pediatr Hem Oncol 2009; 31:920-926.